NCT01194817

Brief Summary

The purpose of this study is to compare the the Nexgen knee replacement system using cementless fixation with the same system using cemented fixation. At minimum 2-year follow-up, the hypothesis is that NexGen total knee arthroplasties using cementless and cemented fixation will demonstrate no differences in clinical outcome based on Oxford and Knee Society scores, patient-assessed visual analog pain, clinical complications, radiographic fixation and implant survivorship.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
7mo left

Started Apr 2010

Longer than P75 for not_applicable knee-osteoarthritis

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Apr 2010Dec 2026

Study Start

First participant enrolled

April 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 3, 2010

Completed
16.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 24, 2023

Status Verified

July 1, 2023

Enrollment Period

16.7 years

First QC Date

September 2, 2010

Last Update Submit

July 20, 2023

Conditions

Keywords

total knee arthroplastytotal knee replacementcementless TKAhigh flexiontrabecular metal

Outcome Measures

Primary Outcomes (15)

  • Radiographic analysis

    Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.

    4 week

  • Radiographic analysis

    Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.

    1 year

  • Radiographic analysis

    Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.

    2 year

  • Radiographic analysis

    Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.

    5 year

  • Radiographic analysis

    Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.

    10 year

  • Radiographic analysis

    Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.

    15 year

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    Date of surgery

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    4 week

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    4 month

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    1 year

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    2 year

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    5 year

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    10 year

  • Complications

    The number and type of adverse events will be monitored to assess safety.

    15 year

  • Radiographic analysis

    Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.

    4 month

Secondary Outcomes (14)

  • Knee Society Score

    4 week

  • Knee Society Score

    1 year

  • Knee Society Score

    2 year

  • Knee Society Score

    5 year

  • Knee Society Score

    10 year

  • +9 more secondary outcomes

Study Arms (2)

Cemented fixation

OTHER

Nexgen High-Flexion Knee Replacement System using Cemented Fixation

Device: High-Flexion Knee Replacement System using Cemented Fixation

Cementless fixation

OTHER

Nexgen High-Flexion Knee Replacement System using Cementless Fixation

Device: High-Flexion Knee Replacement System using Cementless Fixation

Interventions

Eligibility Criteria

AgeUp to 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Primary diagnosis of osteoarthritis of the knee
  • Patients undergoing primary total knee replacement

You may not qualify if:

  • Age over 75 years old
  • Prior unicondylar knee arthroplasty
  • Grossly porotic bone or bone defects requiring bone grafting
  • Bone cuts not sufficiently accurate for cementless fixation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Kevin B Fricka, MD

    Anderson Orthopaedic Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 2, 2010

First Posted

September 3, 2010

Study Start

April 1, 2010

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 24, 2023

Record last verified: 2023-07